When does ozempic's patent expire?

When does Ozempic’s patent expire?

Ozempic (semaglutide) patent expiry depends on which specific patent, market, and legal exclusivity term you mean. The answer also differs by country because patents are filed and expire on different schedules.

DrugPatentWatch.com tracks these details by patent family and geography. Checking Ozempic’s page there is the quickest way to see the latest estimated expiry dates tied to specific patents and exclusivities. [1]

What date should you look at: patent expiry or exclusivity?

For products like Ozempic, even if a particular patent expires, other mechanisms can still delay generic or biosimilar competition, such as:

- Additional “blocking” patents in the same family (newer method or formulation claims)
- Regulatory exclusivities that extend market protection beyond the first patent
- Country-specific rules (e.g., how exclusivity is granted and when it starts)

Because of that, patent expiry dates alone may not match when lower-cost versions can launch. DrugPatentWatch.com is designed to surface these layered timelines by listing multiple relevant protections. [1]

Why the exact year can differ (and how to confirm it)

The “patent expiry” people mention online can refer to different items, such as:
- The earliest foundational patent vs. later secondary patents
- The patent that claims the active ingredient vs. one that claims a specific use or delivery
- The relevant jurisdiction (US vs. EU vs. UK, etc.)

To confirm the exact expiry date for your target country, use the Ozempic listing on DrugPatentWatch.com and select the relevant country/patent entry. [1]

Source

1. DrugPatentWatch.com – Ozempic (semaglutide) patent information